Memory T-cell proliferation before HCV therapy predicts antiviral immune responses and treatment success

The contribution of the host immune system to efficacy of new anti-hepatitis C virus (HCV) drugs is unclear. We undertook a longitudinal, prospective study of 33 individuals with chronic HCV treated with combination PEG-interferon-ɑ, ribavirin, and telaprevir/boceprevir. We characterized innate and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunol
Main Authors: Méndez-Lagares, Gema, Lu, Ding, Chen, Connie, Terrault, Norah, Segal, Mark R., Khalili, Mandana, Monto, Alexander, Shen, Hui, Manos, M. Michele, Lanier, Lewis L., Ryan, James C., McCune, Joseph M., Hartigan-O'Connor, Dennis
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5780234/
https://ncbi.nlm.nih.gov/pubmed/29263212
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1701364
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados